Detailed information for compound 349010

Basic information

Technical information
  • TDR Targets ID: 349010
  • Name: 6-chloro-N-[(4,6-diethoxypyrimidin-2-yl)carba mothioyl]pyridine-3-carboxamide
  • MW: 381.837 | Formula: C15H16ClN5O3S
  • H donors: 2 H acceptors: 4 LogP: 3.37 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOc1cc(OCC)nc(n1)NC(=S)NC(=O)c1ccc(nc1)Cl
  • InChi: 1S/C15H16ClN5O3S/c1-3-23-11-7-12(24-4-2)19-14(18-11)21-15(25)20-13(22)9-5-6-10(16)17-8-9/h5-8H,3-4H2,1-2H3,(H2,18,19,20,21,22,25)
  • InChiKey: MGYUMNOVMOTMMX-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 6-chloro-N-[[(4,6-diethoxy-2-pyrimidinyl)amino]-thioxomethyl]-3-pyridinecarboxamide
  • 6-chloro-N-[(4,6-diethoxypyrimidin-2-yl)thiocarbamoyl]nicotinamide
  • AIDS-349378
  • AIDS349378
  • 3-Pyridinecarboxamide, 6-chloro-N-[[(4,6-diethoxy-2-pyrimidinyl)amino]thioxomethyl]-

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni prolyl oligopeptidase (S09 family) 0.0732 0.2633 0.2633
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.168 1 1
Loa Loa (eye worm) hypothetical protein 0.168 1 1
Trypanosoma brucei prolyl endopeptidase 0.0732 0.2633 0.5
Onchocerca volvulus 0.168 1 1
Loa Loa (eye worm) hypothetical protein 0.0732 0.2633 0.2633
Schistosoma mansoni prolyl oligopeptidase (S09 family) 0.0732 0.2633 0.2633
Brugia malayi prolyl oligopeptidase family protein 0.0732 0.2633 0.2633
Plasmodium falciparum cysteine repeat modular protein 1 0.0392 0 0.5
Toxoplasma gondii prolyl endopeptidase 0.0732 0.2633 1
Echinococcus granulosus prolyl endopeptidase 0.0732 0.2633 1
Onchocerca volvulus Prolyl endopeptidase homolog 0.0732 0.2633 0.2633
Trypanosoma cruzi prolyl endopeptidase 0.0732 0.2633 1
Leishmania major prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative 0.0732 0.2633 1
Mycobacterium tuberculosis Probable protease II PtrBa [first part] (oligopeptidase B) 0.0655 0.2037 0.5
Echinococcus multilocularis prolyl endopeptidase 0.0732 0.2633 1
Plasmodium vivax cysteine repeat modular protein 1, putative 0.0392 0 0.5
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.168 1 1
Onchocerca volvulus 0.152 0.8752 0.8752
Loa Loa (eye worm) hypothetical protein 0.168 1 1

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) 0 Cytotoxicity in MDCK cells using MTS assay ChEMBL. 16216505
IC50 (functional) > 20 uM Inhibitory activity against influenza A3/beijing/30/95(H1N1) virus in MDCK cells ChEMBL. 16216505
IC50 (binding) > 20 uM Inhibition of Influenza A virus neuraminidase activity ChEMBL. 17513019

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.